{"id":579962,"date":"2021-12-22T16:44:02","date_gmt":"2021-12-22T16:44:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=579962"},"modified":"2021-12-22T16:44:02","modified_gmt":"2021-12-22T16:44:02","slug":"west-syndrome-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/west-syndrome-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130_579962.html","title":{"rendered":"West Syndrome Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1640168260.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"West Syndrome Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1640168260.png\" alt=\"West Syndrome Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>West Syndrome Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The current therapeutic landscape of West Syndrome in the United States is shaped by current treatment practices and the anticipated introduction of new therapies.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">West Syndrome market report<\/a><\/strong> offers detailed information on current treatment practices, emerging drugs, West Syndrome market share of the individual therapies, current and forecasted West Syndrome market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Spain, Germany, Italy, and France), and Japan).&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key Takeaways from the West Syndrome Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per DelveInsight estimates, total West Syndrome diagnosed prevalent cases were <strong>8,601<\/strong> in the 7MM in 2020, with the US accounted for the maximum cases&nbsp;<\/li>\n<li>Delvelnsight also examined gender-specific data for West Syndrome, which clearly shows that it is more common in men than women.<\/li>\n<li>Among the EU5 countries, France had the highest diagnosed prevalent cases in 2020.<\/li>\n<li>Leading companies in the West Syndrome market include <strong>Amzell, BioPharm Solutions, Cerecin,<\/strong> and others.<\/li>\n<li>Key West Syndrome pipeline therapies include <strong>AMZ002, JBPOS0101, Tricaprilin,<\/strong> and others.<\/li>\n<li>The FDA has also granted <strong>JBPOS0101 (BioPharm Solutions)<\/strong> Orphan Drug Status for West Syndrome.<\/li>\n<li>The US FDA has granted <strong>AMZ002 (Amzell)<\/strong> Rare Pediatric Disease and Orphan-Drug Designations.&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Request for West Syndrome market report sample to understand more about the emerging drug landscape @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/west-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">West Syndrome Market Landscape<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>West Syndrome Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">West syndrome is an age-related specific epileptic encephalopathy caused by various factors. It is distinguished by a distinct type of seizure known as epileptic (infantile) spasms and gross EEG abnormalities indicative of hypsarrhythmia.<\/p>\n<p style=\"text-align: justify;\"><strong>West Syndrome Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">The West Syndrome report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>West Syndrome Total Prevalent Population<\/li>\n<li>West Syndrome Total Diagnosed Prevalent Population<\/li>\n<li>West Syndrome Gender-Specific Diagnosed Prevalent Population<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>West Syndrome Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\">The major West Syndrome treatment options include:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Corticosteroids and Other off-label therapies<\/li>\n<li>Acthar Gel Injection (Corticotropin; ACTH)<\/li>\n<li>Ketogenic Diet<\/li>\n<li>Sabril (vigabatrin)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>West Syndrome Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The current therapeutic landscape of West Syndrome in the United States is shaped by current treatment practices and the anticipated introduction of new therapies. According to DelveInsight&#8217;s analysts, the West Syndrome market is expected to grow positively during the forecast period, owing primarily to the increased diagnosed prevalence and the launch of upcoming therapies.<\/p>\n<p style=\"text-align: justify;\">Discover more about the future market share of the drugs @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">West Syndrome Market Analysis<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>West Syndrome Pipeline Therapies and Key Companies<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>AMZ002: Amzell<\/li>\n<li>JBPOS0101: BioPharm Solutions<\/li>\n<li>Tricaprilin: Cerecin<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<table border=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td>\n<p>1.<\/p>\n<\/td>\n<td>\n<p>Key Insights<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>2.<\/p>\n<\/td>\n<td>\n<p>West Syndrome Market Overview at a Glance<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>3.<\/p>\n<\/td>\n<td>\n<p>Executive Summary of West Syndrome<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>4.<\/p>\n<\/td>\n<td>\n<p>West Syndrome: Disease Background and Overview<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>5.<\/p>\n<\/td>\n<td>\n<p>Diagnostic Algorithm for West Syndrome<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>6.<\/p>\n<\/td>\n<td>\n<p>Clinical Algorithm for Epileptic Spasms (Infantile Spasms) By Texas Children&rsquo;s Hospital<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>7.<\/p>\n<\/td>\n<td>\n<p>Epidemiology and Patient Population<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>8.<\/p>\n<\/td>\n<td>\n<p>Country Wise-Epidemiology of West Syndrome<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>9.<\/p>\n<\/td>\n<td>\n<p>Treatment<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>10.<\/p>\n<\/td>\n<td>\n<p>Treatment Algorithm for West Syndrome<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>11.<\/p>\n<\/td>\n<td>\n<p>Guidelines for the Management and Treatment of Infantile Seizures<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>12.<\/p>\n<\/td>\n<td>\n<p>Recognized Establishments<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>13.<\/p>\n<\/td>\n<td>\n<p>Unmet Needs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>14.<\/p>\n<\/td>\n<td>\n<p>Marketed Profiles<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>15.<\/p>\n<\/td>\n<td>\n<p>Emerging Drugs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>16.<\/p>\n<\/td>\n<td>\n<p>West Syndrome: 7 Major Market Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>17.<\/p>\n<\/td>\n<td>\n<p>The United States Market Outlook<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>18.<\/p>\n<\/td>\n<td>\n<p>EU-5 Countries: Market Outlook<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>19.<\/p>\n<\/td>\n<td>\n<p>Japan Market Outlook<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>20.<\/p>\n<\/td>\n<td>\n<p>Case Reports<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>21.<\/p>\n<\/td>\n<td>\n<p>Market Drivers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>22.<\/p>\n<\/td>\n<td>\n<p>Market Barriers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>23.<\/p>\n<\/td>\n<td>\n<p>SWOT Analysis of West Syndrome<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>24.<\/p>\n<\/td>\n<td>\n<p>Appendix<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>25.<\/p>\n<\/td>\n<td>\n<p>DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>26.<\/p>\n<\/td>\n<td>\n<p>Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>27.<\/p>\n<\/td>\n<td>\n<p>About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\">Get in touch with our business executive for <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Healthcare Due Diligence Services<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/west-nile-encephalitis-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">West Nile Encephalitis Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s <strong>&#8220;West Nile Encephalitis &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong> report delivers an in-depth understanding of the West Nile Encephalitis, historical and forecasted epidemiology, as well as the West Nile Encephalitis market trends in the 7MM.<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=west-syndrome-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=west-syndrome-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>West Syndrome Market The current therapeutic landscape of West Syndrome in the United States is shaped by current treatment practices and the anticipated introduction of new therapies. DelveInsight&rsquo;s West Syndrome market report offers detailed information on current treatment practices, emerging &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/west-syndrome-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130_579962.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-579962","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/579962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=579962"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/579962\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=579962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=579962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=579962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}